Who Qualifies for Medical Weight Loss at Klinic
Nat Rev Drug Discovery (2022) 21:20123
One innovative therapy we offer involves GLP-1 receptor agonists, such as Ozempic, to effectively support patients in managing type 2 diabetes and achieving their weight-loss goals
Research presented at the European Congress on Obesity in 2024, for instance, found that people who gradually reduced their dose to zero (over an average of nine weeks) maintained a stable body weight in the first 26 weeks after tapering
For effective weight loss treatment, consult with Klinic and consider making the switch to an FDA-approved option like Wegovy, Oral Wegovy, Zepbound, or Foundayo
The team was patient, shared updates at each step, and kept our procurement department informed until the consignment moved